Publications by authors named "Neus Ferrer"

Claim this Profile
L
Liposomal irinotecan in patients with HER2-negative breast cancer and brain metastases: The PHENOMENAL phase 2 study.
Manuel Ruiz Borrego, David Páez López-Bravo, Mireia Margelí Vila, José Manuel Pérez-García, María Fernández, Neus Ferrer

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study.
José Enrique Alés-Martínez, Judith Balmaña, Pedro Sánchez-Rovira, Francisco Javier Salvador Bofill, Jose Ángel García Sáenz, Neus Ferrer

Breast· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19-associated cerebral microbleeds in the general population.
Malini V Sagar, Neus R Ferrer, Mostafa Mehdipour Ghazi, Kiril V Klein, Espen Jimenez-Solem

Brain Commun· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-operative ribociclib plus letrozole versus chemotherapy: Health-related quality of life outcomes from the SOLTI CORALLEEN trial.
Guillermo Villacampa, Claudette Falato, Laia Paré, Cristina Hernando, Miriam Arumí, Neus Ferrer

Eur J Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial.
Aleix Prat, Cristina Saura, Tomás Pascual, Cristina Hernando, Montserrat Muñoz, Neus Ferrer

Lancet Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis